DOSTINEX 0.5 MG (8 TABLETS) - 8 tabs by Pfizer
Pfizer

DOSTINEX 0.5 MG (8 TABLETS)

CLASSIFICATION: DOPAMINE D2 AGONIST (ERGOLINE)
ACTIVE SUBSTANCE: CABERGOLINE
FORM: 8 TABLETS x 0.5 MG
ACTIVE HALF-LIFE: ~63–69 HOURS
DOSAGE: MEN 0.25 MG/WEEK
ACNE: LOW / NOT TYPICAL
WATER RETENTION: NONE EXPECTED
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: NONE EXPECTED
AROMATIZATION: NONE
MANUFACTURER: PFIZER

55.00 USD
Shipping From:
International

DOSTINEX 0.5 MG (8 TABLETS) Detailed

Dostinex 0.5 mg (Cabergoline) by Pfizer — Precision Control for Elevated Prolactin

Dostinex contains cabergoline, a long-acting dopamine D2 receptor agonist used under medical supervision to manage disorders associated with elevated prolactin. In performance contexts, athletes sometimes encounter prolactin-related symptoms—such as low libido, mood changes, or nipple discharge—particularly when using 19-nor compounds. While lifestyle factors and cycle design are the first lines of defense, clinically managed cabergoline may be prescribed by a physician to normalize prolactin and relieve associated symptoms.

Important: Dostinex is a prescription medication. Use it only under the guidance of a licensed healthcare professional. It is not a substitute for a well-planned protocol or post-cycle strategy.

What Cabergoline Does

Cabergoline selectively stimulates dopamine D2 receptors in the pituitary to reduce prolactin secretion. When prolactin normalizes, users commonly report a steadier mood, better sexual wellbeing, and fewer prolactin-linked side effects. Because cabergoline is long-acting, its effect persists between scheduled doses, supporting consistent control without day-to-day fluctuations.

Who It's For (and Not For)

  • For: Adults with clinically elevated prolactin confirmed by lab work, under a doctor's care.
  • Not for: Individuals without documented hyperprolactinemia; those who are pregnant or breastfeeding; anyone with known valvular heart disease or fibrotic disorders unless cleared by a physician.

In situations where estradiol is also elevated, managing estrogen remains essential. Consider a physician-guided aromatase inhibitor alongside lifestyle changes. For reference, see our in-stock options like Dragon Pharma Arimidex (Anastrozole) and Dragon Pharma Letrozole.

How to Use

Form & strength: 0.5 mg tablets (8 per pack).
Label-based initiation: Many clinicians start at 0.25 mg twice weekly and reassess labs after several weeks, adjusting in small steps to the lowest effective dose. Your doctor will set the schedule that fits your case.

Timing: Because cabergoline has a multi-day active half-life, twice-weekly dosing is common in clinical practice. Taking tablets with food may improve GI tolerance. Do not exceed your prescriber's instructions.

Avoid "self-correction": If you overshoot and drive prolactin too low, you may see the opposite problem (e.g., low libido, fatigue). Always titrate under medical supervision and confirm with labs.

Authoritative reference on indications, dosing principles, and safety can be found in the FDA Prescribing Information for Dostinex.

Safety & Precautions

Cabergoline is generally well tolerated, but it can cause nausea, dizziness/orthostatic hypotension (lightheadedness when standing), headache, and occasionally sleep disturbances. Rarely, dopamine agonists are associated with impulse-control issues or mood changes. Discontinue and seek medical help if you experience chest pain, shortness of breath, swelling, new heart murmur, or severe mood changes.

Heart & fibrosis considerations: Long-term use of certain ergot-derived dopamine agonists has been linked—mostly at higher cumulative doses—to valvular and extrapulmonary fibrotic effects. For patients on extended therapy, clinicians often evaluate cardiovascular status and may order baseline and periodic echocardiography. Your provider will decide what monitoring is appropriate for you.

Interactions & conflicts: Avoid combining with dopamine antagonists (e.g., some antipsychotics) that counteract cabergoline's effect. Alcohol, dehydration, or stimulants may exacerbate dizziness. Always disclose all medications and supplements to your clinician.

Where It Fits in a Complete Strategy

Cabergoline is not a replacement for estrogen management or a comprehensive recovery plan. If your protocol also requires PCT, physician-guided SERMs are standard options. Explore our related inventory to plan your stack responsibly:

Using a targeted AI during aromatizable cycles, followed by smart SERM-based recovery, can address the root causes of estrogen/prolactin imbalance rather than "chasing symptoms." Cabergoline, when indicated by labs, complements (not replaces) those fundamentals.

Quality & Authenticity

This listing is for genuine Pfizer Dostinex 0.5 mg tablets (8 count). We store inventory properly and ship discreetly. As always, use under supervision and in accordance with local laws.

Key Takeaways

  • Long-acting dopamine agonist designed to lower prolactin and relieve related symptoms.
  • Typical label-based initiation is low (0.25 mg twice weekly) with adjustments by labs.
  • Works best as part of a comprehensive plan that also addresses estrogen control and recovery.
  • Prescription-only with safety monitoring determined by your clinician.

Disclaimer: The content above is informational and not medical advice. Always consult a licensed healthcare professional before using prescription medication.

Frequently Asked Questions

What does Dostinex (cabergoline) do?

Cabergoline is a dopamine D2 agonist that reduces prolactin release from the pituitary. When prescribed for hyperprolactinemia, normalizing prolactin may improve energy, libido, and other prolactin-linked symptoms.

How is it typically dosed according to labeling?

Clinicians often start at 0.25 mg twice weekly and titrate slowly to the lowest effective dose, reassessing labs after several weeks. Use only as prescribed by your doctor.

How long is the half-life and how often is it taken?

Cabergoline has a multi-day elimination half-life (about 63–69 hours in healthy subjects), so twice-weekly schedules are common in clinical use. Your clinician sets the exact plan.

What side effects or warnings should I know about?

Possible effects include nausea, dizziness (especially on standing), headache, and sleep changes. Long-term therapy may require clinician-directed heart monitoring due to rare valvular/fibrotic risks. Seek care for chest pain, swelling, breathlessness, or severe mood changes.

Can I combine it with estrogen control or PCT agents?

Often, yes—when supervised by a clinician. Estrogen management (e.g., with an aromatase inhibitor) and SERM-based PCT address root causes. See related options like Dragon Pharma Arimidex, Letrozole, Clomid, Enclomiphene, and HCG.

No reviews found

Please log in to write DOSTINEX 0.5 MG (8 TABLETS) review.

Related Offers
DOSTINEX 0.5 MG - 100 tabs by Generic
Generic

CLASSIFICATION: DOPAMINE RECEPTOR AGONIST
ACTIVE SUBSTANCE: CABERGOLINE
FORM: 100 PILLS x 0.5 MG
ACTIVE HALF-LIFE: FIRST-PASS EFFECT SEEN
DOSAGE: MEN 0.25 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: GENERIC

Out of stock
CABERLIN 0.25 - 12 tabs by Sun Pharma, India
Sun Pharma, India

CLASSIFICATION: DOPAMINE RECEPTOR AGONIST
ACTIVE SUBSTANCE: CABERGOLINE
FORM: 12 PILLS x 0.25 MG
ACTIVE HALF-LIFE: FIRST-PASS EFFECT SEEN
DOSAGE: MEN 0.25 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: SUN PHARMA

Out of stock
CABERLIN 0.5 - 12 tabs by Sun Pharma, India
Sun Pharma, India

CLASSIFICATION: DOPAMINE RECEPTOR AGONIST
ACTIVE SUBSTANCE: CABERGOLINE
FORM: 12 PILLS x 0.5 MG
ACTIVE HALF-LIFE: FIRST-PASS EFFECT SEEN
DOSAGE: MEN 0.25 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: SUN PHARMA

Out of stock
CABGOLIN 0.5 - 16 tabs by Sun Pharma, India
Sun Pharma, India

CLASSIFICATION: DOPAMINE RECEPTOR AGONIST
ACTIVE SUBSTANCE: CABERGOLINE
FORM: 20 PILLS x 0.5 MG
ACTIVE HALF-LIFE: FIRST-PASS EFFECT SEEN
DOSAGE: MEN 0.25 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: SUN PHARMA

Out of stock
CABGOLIN 0.25 - 16 tabs by Sun Pharma, India
Sun Pharma, India

CLASSIFICATION: DOPAMINE RECEPTOR AGONIST
ACTIVE SUBSTANCE: CABERGOLINE
FORM: 8 PILLS x 0.25 MG
ACTIVE HALF-LIFE: FIRST-PASS EFFECT SEEN
DOSAGE: MEN 0.25 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: SUN PHARMA

Out of stock
Shipped International
GENOTROPIN 36 IU - vial by Pfizer, Turkey
Pfizer, Turkey

CLASSIFICATION: RECOMBINANT HUMAN GROWTH HORMONE (rHGH)
ACTIVE SUBSTANCE: SOMATROPIN
FORM: 1 PRE-FILLED PEN x 36 IU (12 MG)
ACTIVE HALF-LIFE: ~3.5 HOURS (SUBQ)
DOSAGE: 1–4 IU/DAY FOR ANTI-AGING; 4–8 IU/DAY FOR FAT LOSS OR PERFORMANCE
WATER RETENTION: POSSIBLE (DOSE DEPENDENT)
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PFIZER

330.00 USD  
Shipped International
AROMASIN - 30 tabs by Pfizer
Pfizer

CLASSIFICATION: STEROIDAL AROMATASE INHIBITOR (AI)
ACTIVE SUBSTANCE: EXEMESTANE
FORM: 30 TABLETS x 25 MG
ACTIVE HALF-LIFE: ~24 HOURS
DOSAGE: MEN 25 MG ONCE DAILY
ACNE: POSSIBLE
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: RARE
AROMATIZATION: NONE
MANUFACTURER: PFIZER

90.00 USD  
Shipped International
Viagra 100 mg - 4 tabs by Pfizer
Pfizer

CLASSIFICATION: PDE5 INHIBITOR (ERECTILE DYSFUNCTION)
ACTIVE SUBSTANCE: SILDENAFIL CITRATE
FORM: 4 TABLETS x 100 MG
ACTIVE HALF-LIFE: ~4 HOURS
DOSAGE: MEN 50-100 MG/DAY
ACNE: NOT APPLICABLE
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): MAY LOWER BP
HEPATOTOXICITY: NOT TYPICAL
AROMATIZATION: NONE
MANUFACTURER: PFIZER

90.00 USD  

Add in Cart - Product(s)

Close Button
Empty

Total Cost: